Evidence map›Paper›PMID 35094211›Full record

ArticleJournal of molecular histology2022

Endocrine secretory granule production is caused by a lack of REST and intragranular secretory content and accelerated by PROX1.

Jun Ishii, Hanako Sato-Yazawa, Korehito Kashiwagi, Kazuhiko Nakadate, Masami Iwamoto, Kakeru Kohno, Chie Miyata-Hiramatsu, Meitetsu Masawa, Masato Onozaki, Shuhei Noda and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular histology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Jun IshiiDepartment of Pathology, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Tochigi, Japan.ORCID http://orcid.org/0000-0001-9623-5442
Hanako Sato-YazawaDepartment of Pathology, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Tochigi, Japan.ORCID http://orcid.org/0000-0002-9594-2169
Korehito KashiwagiDepartment of Pathology, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Tochigi, Japan.ORCID http://orcid.org/0000-0002-5099-5793
Kazuhiko NakadateEducation Research Center, Meiji Pharmaceutical University, Kiyose-shi, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6717-7167
Masami IwamotoDepartment of Pathology, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Tochigi, Japan.ORCID http://orcid.org/0000-0003-3418-5595
Kakeru KohnoDepartment of Pathology, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Tochigi, Japan.ORCID http://orcid.org/0000-0002-3967-3662
Chie Miyata-HiramatsuDepartment of Pathology, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Tochigi, Japan.ORCID http://orcid.org/0000-0002-2140-0295
Meitetsu MasawaDepartment of Respiratory Medicine, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Tochigi, Japan.ORCID http://orcid.org/0000-0002-7091-3097
Masato OnozakiDepartment of Diagnostic Pathology, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Tochigi, Japan.ORCID http://orcid.org/0000-0003-1819-8871
Shuhei NodaDepartment of Diagnostic Pathology, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Tochigi, Japan.ORCID http://orcid.org/0000-0002-3006-9055
Tadasuke MiyazawaDepartment of Pathology, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Tochigi, Japan.ORCID http://orcid.org/0000-0001-5801-5625
Megumi TakagiDepartment of Pathology, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Tochigi, Japan.ORCID http://orcid.org/0000-0002-0627-3742
Takuya YazawaDepartment of Pathology, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu-machi, Tochigi, Japan. tkyazawa@dokkyomed.ac.jp.ORCID http://orcid.org/0000-0002-0093-102X
Dokkyo Medical University · JPDokkyo University · JPJikei University School of Medicine · JPMeiji Pharmaceutical University · JPToyo University · JP

Funding

Japan Society for the Promotion of Science JP21K06742
6 · The paper itself

Abstract

Endocrine secretory granules (ESGs) are morphological characteristics of endocrine/neuroendocrine cells and store peptide hormones/neurotransmitters. ESGs contain prohormones and ESG-related molecules, mainly chromogranin/secretogranin family proteins. However, the precise mechanism of ESG formation has not been elucidated. In this study, we experimentally induced ESGs in the non-neuroendocrine lung cancer cell line H1299. Since repressive element 1 silencing transcription factor (REST) and prospero homeobox 1 (PROX1) are closely associated with the expression of ESG-related molecules, we edited the REST gene and/or transfected PROX1 and then performed molecular biology, immunocytochemistry, and electron and immunoelectron microscopy assays to determine whether ESG-related molecules and ESGs were induced in H1299 cells. Although chromogranin/secretogranin family proteins were induced in H1299 cells by knockout of REST and the induction was accelerated by the PROX1 transgene, the ESGs could not be defined by electron microscopy. However, a small number of ESGs were detected in the H1299 cells lacking REST and expressing pro-opiomelanocortin (POMC) by electron microscopy. Furthermore, many ESGs were produced in the REST-lacking and PROX1- and POMC-expressing H1299 cells. These findings suggest that a lack of REST and the expression of genes related to ESG content are indispensable for ESG production and that PROX1 accelerates ESG production.Trial registration: Not applicable.

Indexed as

ChromograninsGenes, HomeoboxPro-OpiomelanocortinSecretory VesiclesTranscription FactorsChromograninsPro-OpiomelanocortinTranscription FactorsEndocrine secretory granuleNon-neuroendocrine lung cancerPOMCPROX1REST

Identifiers

PMID35094211
PMCPMC9117388
OpenAlexW4210664193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.